Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/49150| Title: | Pharmacotherapy in the treatment of clostridium difficile : impact on clinical practice |
| Authors: | Holgado Sánchez, Noelia Vella, Janis Barbara, Christopher Azzopardi, Lilian M. |
| Keywords: | Clostridium difficile -- Chemotherapy Clostridium difficile -- Risk factors Microbial sensitivity tests |
| Issue Date: | 2017-09 |
| Publisher: | University of Malta. Department of Pharmacy |
| Citation: | Holgado Sánchez, N.,Vella, J., Barbara, C., & Azzopardi, L. M. (2017, September). Pharmacotherapy in the treatment of clostridium difficile: impact on clinical practice. Poster session presented at the 77th FIP Annual Conference, Seoul, Republic of Korea. |
| Abstract: | A poster presentation regarding pharmacotherapy in the treatment of clostridium difficile and the impact on clinical practice. Introduction: Clostridium difficile is a pathogen accounting for 20-30% of cases of antibiotic-associated diarrhoea and is the most common cause of hospital-acquired diarrhoea. Transmission takes place by faecal-oral route. Colonization can be symptomatic or asymptomatic. Risk factors for C. difficile infection (CDI) include: recent or concomitant antibiotic exposure, older age, length of hospital stay, gastric acid suppression and immunosuppression. Aims: • To propose a framework for C. difficile culturing and antibiotic sensitivity testing with standardization of this testing procedure. • To identify risk factors for CDI and carriage of this infection. |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/49150 |
| Appears in Collections: | Scholarly Works - FacM&SPha |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Pharmacotherapy_in_the_treatment_of_clostridium_difficile_impact_on_clinical_practice_2017.pdf | 560.54 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.